Disease/Infection News

RSS

BIOTECON Diagnostics releases microproof SARS-CoV-2 Screening/Identification Kits

BIOTECON Diagnostics has developed and launched its own microproof SARS-CoV-2 Screening/Identification Kits, which are available immediately for purchase and can be distributed globally.

29 Apr 2020

Critical Care experts share roadmap for meeting challenges posed by COVID-19 pandemic

Hospitals facing a growing population of COVID-19 cases need a coordinated approach with a multidisciplinary team to increase efficiency, conserve PPE and protect staff.

29 Apr 2020

GlobalData: Mass home testing for Covid-19 isn’t without its risks

Unfettered access to rapid and safe Covid-19 tests will be one of the most critical factors in reducing the spread of the disease.

29 Apr 2020

UEA Health Sciences students and staff respond to the fight against COVID-19

Following a nationwide call for support for the NHS workforce, UEA students and staff have responded in their numbers, from undertaking placements to training former healthcare professionals who are re-joining the service at this time of national emergency.

29 Apr 2020

GlobalData offers view on Gilead’s suspension of Covid-19 trials in China

Following the news that China trials of Gilead Sciences Inc’s antiviral drug remdesivir in patients with mild symptoms of coronavirus have been suspended due to lack of eligible patients;

From Gilead Sciences, Inc. 29 Apr 2020

Tips to make safe transitions between nursing home and emergency departments during COVID-19

The COVID-19 pandemic has severely impacted nursing home residents, and many have been hospitalized.

29 Apr 2020

International study to evaluate the effects of COVID-19 in pregnancy launched

Researchers at the University of Oxford are today starting a large, international study to evaluate the effects of COVID-19 in pregnancy.

29 Apr 2020

Study with twins shows COVID-19 symptoms have genetic contribution

A new study published on the preprint server medRxiv from King's College, London, suggests that an individual's genetic makeup may contribute to how much a person is likely to be affected by COVID-19, or whether they are likely to be infected at all.

29 Apr 2020

GlobalData: PPE shortage to drive adoption of robots to treat Covid-19 patients in India

Healthcare professionals are one of the most vulnerable groups exposed to infections. Rising number of coronavirus cases and severe shortage of personal protective equipment products across India are putting them at more risk.

29 Apr 2020

Ortho introduces second COVID-19 antibody test with 100% specificity

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today introduced and announced the U.S. Food and Drug Administration granted Emergency Use Authorization to its second COVID-19 antibody test—the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test. This test is one of only a handful of antibody tests to be granted Emergency Use Authorization.

From Ortho-Clinical Diagnostics, Inc. 29 Apr 2020

Study reveals SARS-CoV-2 RNA cap structure

A new study published on the preprint server bioRxiv in April 2020 reports the discovery of the structure of the cap created by the novel coronavirus on virally encoded mRNAs. The finding could help create new antiviral strategies.

29 Apr 2020

'Smart sample pooling' for COVID-19 could solve test kit shortage problem

A new study from Pakistan suggests 'smart sample pooling' using population grouping with algorithms as a solution to the unavailability of test kits for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a virus that causes COVID-19 disease. The paper is published on the preprint server medRxiv on April 28, 2020.

29 Apr 2020

How weather and demographics influence the COVID-19 spread

What can stop the spread of the novel coronavirus? A new study published in the preprint journal medRxiv in April 2020 debunks the idea that warmer and more humid conditions can hinder the pandemic from spreading with ease.

29 Apr 2020

AGS publishes policy brief to address COVID-19 concerns in assisted living facilities

In a policy brief published today in its namesake journal, the American Geriatrics Society (AGS) offered a roadmap to guide federal, state, and local governments addressing COVID-19 concerns in an important but oft-overlooked arena: Assisted living facilities (ALFs).

29 Apr 2020

How toxic are chloroquine and hydroxychloroquine to cells?

The spread of the pandemic disease COVID-19 caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has now reached almost every country of the world, with over 3.11 million cases and over 217,000 deaths as of April 29, 2020.

29 Apr 2020

Computer vision system detects fever remotely to rule out COVID-19

People who approach the front desk at Albert Einstein Jewish Hospital (HIAE) in the city of São Paulo have their temperature taken remotely by a computer vision system installed in a nearby column.

29 Apr 2020

Study highlights biases and social implications in COVID-19 crisis

The biases individuals harbor against people they see as physically dirty emerge in children as young as five years old and persist into adulthood, according to a new study by researchers from Boston College and Franklin & Marshall College, who found these prejudices extend to the sick and may hold implications for people diagnosed with Covid-19.

29 Apr 2020

Men are twice more likely to die of COVID-19 than women

There have been studies that have revealed that men are more likely to get more severe symptoms from COVID-19 disease and also more likely to die from complications of the disease. A new study corroborates these findings. The study titled, “Gender differences in patients with COVID-19: Focus on severity and mortality,” is published in the latest issue of the journal Frontiers in Public Health.

29 Apr 2020

Epivax and Entos Pharmaceuticals to develop DNA-based vaccine for COVID-19

Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced a collaboration with EpiVax, Inc. (EpiVax), a world leading informatics and immunology biotechnology company with a proven track record in vaccine development.

28 Apr 2020

French scientists suggest nicotinic agonists could treat COVID-19

Contrary to the warnings issued by health agencies worldwide against cigarette smoking amid the coronavirus disease (COVID-19), a new paper suggests the possibility that nicotine, a component of tobacco, could prevent coronavirus infection.

28 Apr 2020